While sequencing the exomes of patients with rare diseases may end their diagnostic odysseys and possibly offer treatment ideas, insurers are beginning to re-think reimbursing such tests, Reuters reports. Insurance companies argue that there is no proof that sequencing results will lead to "meaningful treatments," the news agency adds.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.